Alberto Romero-Palacios

902 total citations
23 papers, 263 citations indexed

About

Alberto Romero-Palacios is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Alberto Romero-Palacios has authored 23 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Alberto Romero-Palacios's work include HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (7 papers). Alberto Romero-Palacios is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (7 papers). Alberto Romero-Palacios collaborates with scholars based in Spain, Canada and Chile. Alberto Romero-Palacios's co-authors include Juan A. Pineda, Esperanza Merino, Nicolás Merchante, Manuel Márquez, Francisco Téllez, Antonio Rivero, Enrique Ortega, Maria José Ríos-Villegas, José López-Aldeguer and Francisco Jover and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Alberto Romero-Palacios

20 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alberto Romero-Palacios Spain	10	114	103	79	50	29	23	263
Yann Quertainmont France	7	114 1.0×	64 0.6×	85 1.1×	9 0.2×	35 1.2×	14	200
Dorcas Owusu Ghana	8	88 0.8×	33 0.3×	78 1.0×	15 0.3×	31 1.1×	26	164
Chiara Bellacosa Italy	9	79 0.7×	35 0.3×	104 1.3×	44 0.9×	54 1.9×	18	234
Maria Cristina Uccelli Italy	10	81 0.7×	36 0.3×	120 1.5×	21 0.4×	54 1.9×	16	216
María Jesús Jiménez‐Expósito United States	8	162 1.4×	163 1.6×	67 0.8×	11 0.2×	34 1.2×	12	266
Israel Grilo Bensusán Spain	7	193 1.7×	255 2.5×	49 0.6×	105 2.1×	15 0.5×	12	315
Raj K. Medapalli United States	6	36 0.3×	38 0.4×	88 1.1×	50 1.0×	36 1.2×	7	240
Jennifer Leong United States	8	123 1.1×	91 0.9×	48 0.6×	17 0.3×	5 0.2×	15	195
Matthijs van Luin Netherlands	10	67 0.6×	24 0.2×	136 1.7×	20 0.4×	57 2.0×	27	260
Alain Landau France	9	295 2.6×	314 3.0×	163 2.1×	46 0.9×	39 1.3×	14	436

Countries citing papers authored by Alberto Romero-Palacios

Since Specialization

Citations

This map shows the geographic impact of Alberto Romero-Palacios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Romero-Palacios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Romero-Palacios more than expected).

Fields of papers citing papers by Alberto Romero-Palacios

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Romero-Palacios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Romero-Palacios. The network helps show where Alberto Romero-Palacios may publish in the future.

Co-authorship network of co-authors of Alberto Romero-Palacios

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Romero-Palacios. A scholar is included among the top collaborators of Alberto Romero-Palacios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Romero-Palacios. Alberto Romero-Palacios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buzón, Luís, Alfonso Cabello, Marı́a José Galindo, et al.. (2025). Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges ahead. Journal of Antimicrobial Chemotherapy. 80(10). 2565–2586.

Vivancos, María Jesús, David Vinuesa García, Antonio Collado, et al.. (2025). Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. PLoS ONE. 20(9). e0323167–e0323167.

Serna‐Gallego, Ana, María Trujillo‐Rodríguez, Ana Isabel Álvarez‐Ríos, et al.. (2025). Randomized clinical trial to evaluate the longitudinal HIV-1 reservoir and inflammation in treatment-naïve people starting dolutegravir/lamivudine versus dolutegravir plus tenofovir alafenamide/emtricitabine. Clinical Microbiology and Infection. 32(1). 154–160.

Hidalgo‐Tenorio, Carmen, María Jesús Vivancos, David Vinuesa García, et al.. (2024). Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial. International Journal of Antimicrobial Agents. 63(6). 107164–107164. 6 indexed citations

León‐López, Rafael, Alberto Romero-Palacios, Jesús Rodríguez‐Baño, et al.. (2020). Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial. BMJ Open. 10(11). e039951–e039951. 10 indexed citations

Romero-Palacios, Alberto, Danielle Petruccelli, Cheryl Main, et al.. (2019). Screening for and decolonization of Staphylococcus aureus carriers before total joint replacement is associated with lower S aureus prosthetic joint infection rates. American Journal of Infection Control. 48(5). 534–537. 16 indexed citations

Romero-Palacios, Alberto, et al.. (2018). Unsolicited consultation by infectious diseases specialist improves outcomes in patients with bloodstream infection: A prospective cohort study. Journal of Infection. 77(6). 503–508. 7 indexed citations

Pasquau, Juan, Carmen Hidalgo-Tenorio, Marisa Montes, et al.. (2018). High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial. PLoS ONE. 13(4). e0195068–e0195068. 30 indexed citations

Romero-Palacios, Alberto, et al.. (2018). Traqueobronquitis obstructiva por Aspergillus fumigatus en un paciente inmunocompetente. Revista Iberoamericana de Micología. 36(1). 34–36. 3 indexed citations

10.

Romero-Palacios, Alberto, Richard Whitlock, Shun Fu Lee, et al.. (2018). Prevention of Infections in Cardiac Surgery study (PICS): study protocol for a pragmatic cluster-randomized factorial crossover pilot trial. Trials. 19(1). 595–595. 9 indexed citations

11.

Romero-Palacios, Alberto, et al.. (2018). Resistance patterns of Enterobacteriaceae in urines are similar in symptomatic and asymptomatic patients. Journal of Hospital Infection. 99(4). 419–421. 1 indexed citations

12.

Palacios, Rosario, Carmen María González-Domenech, Mohamed Omar, et al.. (2016). Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART. European Journal of Clinical Microbiology & Infectious Diseases. 35(5). 815–819. 11 indexed citations

13.

Merchante, Nicolás, Sofía Ibarra, Boris Revollo, et al.. (2016). Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients. AIDS. 31(1). 89–95. 12 indexed citations

14.

López‐Cortés, Luís F., Miguel Ángel López‐Ruz, Maria José Ríos-Villegas, et al.. (2016). Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens. PLoS ONE. 11(2). e0148924–e0148924. 14 indexed citations

15.

López‐Cortés, Luís F., Pompeyo Viciana, J.A. Girón González, et al.. (2014). Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population. PLoS ONE. 9(5). e97262–e97262. 4 indexed citations

16.

Toro, María Dolores del, I. Nieto, Juan E. Corzo, et al.. (2014). Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures. European Journal of Clinical Microbiology & Infectious Diseases. 33(8). 1439–1448. 25 indexed citations

17.

Blanco, José Ramón, Ana María Caro-Murillo, Julián Olalla, et al.. (2013). Safety, Efficacy, and Persistence of Emtricitabine/Tenofovir Versus Other Nucleoside Analogues in Naive Subjects Aged 50 Years or Older in Spain: The TRIP Study. HIV Clinical Trials. 14(5). 204–215. 2 indexed citations

18.

Merchante, Nicolás, Esperanza Merino, Francisco Rodríguez-Arrondo, et al.. (2013). HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma. AIDS. 28(1). 41–47. 25 indexed citations

19.

Merchante, Nicolás, Esperanza Merino, José López-Aldeguer, et al.. (2012). Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain. Clinical Infectious Diseases. 56(1). 143–150. 51 indexed citations

20.

Romero-Palacios, Alberto, et al.. (2008). Leucoencefalopatía posterior reversible en una paciente con eclampsia posparto. Medicina Intensiva. 32(7). 361–363. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact